| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | BRD-K90370028 | CTRPv2 | pan-cancer | AAC | 0.088 | 0.1 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |
| mRNA | purmorphamine | CTRPv2 | pan-cancer | AAC | -0.06 | 0.1 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | alvocidib | CTRPv2 | pan-cancer | AAC | 0.078 | 0.1 |
| mRNA | ML311 | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |